India, Oct. 3 -- ZoeNCure Therapeutics, a Delhi-based oncology biotechnology startup focused on developing high-potency targeted cancer therapies, has announced the successful closing of Rs 20 Crore (approx. $2.4 Million) Seed financing round.

The investment was led by the HNI (High-Net-Worth Individual) Tyagi Family based out of Gurugram, led by Shyambir Tyagi and Manoj Tyagi, alongside participating angel co-investors.

This round represents the second financial backing from the said Tyagi Family, which previously provided an Rs 2.5 crore pre-seed investment to fund ZoeNCure's foundational operations. The follow-on capital brings the total equity raised by the company to Rs 22.5 crore.

Proceeds from the seed round will be utilised to ...